National Cancer Institute; Notice of Meeting, 42313 [E9-20170]

Download as PDF Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices Medicine, Chicago, Illinois, at telephone number 312–503–3659 or e-mail address jkhirsch@northwestern.edu. At the conclusion of the regional meetings, the ORWH will hold a meeting at the NIH to summarize the deliberations from the regional conferences. The resulting report to the ORWH and the NIH will ensure that women’s health research in the coming decade continues to support a vigorous research agenda incorporating the latest advances in technology and cuttingedge science. Dated: August 13, 2009. Raynard S. Kington, Acting Director, National Institutes of Health. [FR Doc. E9–20149 Filed 8–20–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting srobinson on DSKHWCL6B1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Cancer Institute Director’s Consumer Liaison Group. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Cancer Institute Director’s Consumer Liaison Group. Date: October 20–22, 2009. Time: October 20, 2009, 2 p.m. to 6 p.m. Agenda: Welcome, Overview of the NCI Advanced Therapeutics Platform, Expert Panel on NCI Therapeutics Platform. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Time: October 21, 2009, 8:30 a.m. to 5:30 p.m. Agenda: Gaining Community Input on NCI Therapeutics Platform, Communicating with the Community About the NCI Therapeutics Platform, Advocates in Research Working Group Discussion, NCI National Outreach Network Discussion. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Time: October 22, 2009, 8:30 a.m. to 1 p.m. Agenda: Communicating with the Community about the NCI Therapeutics Platform (cont’d), Engaging the Community Around the NCI Therapeutics Platform, Discussion with NCI Director. VerDate Nov<24>2008 16:22 Aug 20, 2009 Jkt 217001 Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Contact Person: Benjamin Carollo, MPA, Advocacy Relations Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892–2580. 301–496–0307. carollob@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page:https:// deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: August 17, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–20170 Filed 8–20–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Environmental Health Sciences Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 42313 notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Environmental Health Sciences Council. Date: September 15–16, 2009. Open: September 15, 2009, 8:30 a.m. to 5 p.m. Agenda: Discussion of program policies and issues. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Open: September 16, 2009, 8:30 a.m. to 10:30 a.m. Agenda: Discussion of program policies and issues. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Closed: September 16, 2009, 10:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Contact Person: Gwen W Collman, PHD, Interim Director, Division of Extramural Research & Training, National Institutes of Health, Nat. Inst. of Environmental Health Sciences, 615 Davis Dr., KEY615/3112, Research Triangle Park, NC 27709, (919) 541– 4980, collman@niehs.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niehs.nih.gov/dert/c-agenda.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Page 42313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20170]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: October 20-22, 2009.
    Time: October 20, 2009, 2 p.m. to 6 p.m.
    Agenda: Welcome, Overview of the NCI Advanced Therapeutics 
Platform, Expert Panel on NCI Therapeutics Platform.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Time: October 21, 2009, 8:30 a.m. to 5:30 p.m.
    Agenda: Gaining Community Input on NCI Therapeutics Platform, 
Communicating with the Community About the NCI Therapeutics 
Platform, Advocates in Research Working Group Discussion, NCI 
National Outreach Network Discussion.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Time: October 22, 2009, 8:30 a.m. to 1 p.m.
    Agenda: Communicating with the Community about the NCI 
Therapeutics Platform (cont'd), Engaging the Community Around the 
NCI Therapeutics Platform, Discussion with NCI Director.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Contact Person: Benjamin Carollo, MPA, Advocacy Relations 
Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 
Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, 
Bethesda, MD 20892-2580. 301-496-0307. carollob@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page:https://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20170 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.